Systemic inflammation and the brain: Novel roles of genetic, molecular, and environmental cues as drivers of neurodegeneration

Frontiers in Cellular Neuroscience

Volumn 9, Issue FEB, 2015, Pages

  Sankowski, Roman ^a,b   Mader, Simone ^b   Valdés Ferrer, Sergio Iván ^a,b,c  

^a Elmezzi Graduate School of Molecular Medicine   (United States)

^b FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^c INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Anti brain antibodies; Autoimmune disorders; Connectome; HMGB1; Neurodegeneration; Systemic inflammation and sepsis; TNF

Indexed keywords

AQUAPORIN 4; CD68 ANTIGEN; EXODEOXYRIBONUCLEASE III; GLIAL FIBRILLARY ACIDIC PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN; HLA DRB1 ANTIGEN; INTERLEUKIN 1; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MINOCYCLINE; N ACETYLASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; REACTIVE OXYGEN METABOLITE; SCAVENGER RECEPTOR A; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANHEDONIA; ANXIETY; APOPTOSIS; ARTICLE; B LYMPHOCYTE; BACTEREMIA; BARE LYMPHOCYTE SYNDROME; BRAIN DYSFUNCTION; COGNITIVE DEFECT; DELIRIUM; HUMAN; IMMUNE SYSTEM; IMMUNOLOGICAL PARAMETERS; IMMUNOPATHOLOGY; INFLAMMATION; INJURY; MACROPHAGE; MICROGLIA; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NEWBORN SEPSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERSISTENT IMMUNE ACTIVATION; SEPSIS ASSOCIATED ENCEPHALOPATHY; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

EID: 84961289646     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2015.00028     Document Type: Article

References (279)

1. Abbott, N. J., Ronnback, L., and Hansson, E. (2006). Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 7, 41-53. doi:10.1038/nrn1824
2. Achard, S., Salvador, R., Whitcher, B., Suckling, J., and Bullmore, E. (2006). A resilient, low-frequency, small-world human brain functional network with highly connected association cortical hubs. J. Neurosci. 26, 63-72. doi:10.1523/JNEUROSCI.3874-05.2006
3. Ainiala, H., Loukkola, J., Peltola, J., Korpela, M., and Hietaharju, A. (2001). The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology 57, 496-500. doi:10.1212/WNL.57.3.496
4. Aktas, O., Smorodchenko, A., Brocke, S., Infante-Duarte, C., Schulze Topphoff, U., Vogt, J., et al. (2005). Neuronal damage in autoimmune neuroinflammation mediated bythe death ligand TRAIL. Neuron 46, 421-432. doi:10.1016/j.neuron.2005.03.018
5. Alaedini, A., Okamoto, H., Briani, C., Wollenberg, K., Shill, H. A., Bushara, K. O., et al. (2007). Immune cross-reactivity in celiac disease: anti-gliadin antibodies bind to neuronal synapsin I. J. Immunol. 178, 6590-6595. doi:10.4049/jimmunol.178.10.6590
6. Allaman, I., Belanger, M., and Magistretti, P. J. (2011). Astrocyte-neuron metabolic relationships: For better and for worse. Trends Neurosci. 34, 76-87. doi:10.1016/j.tins.2010.12.001
7. Anderson, S. T., Commins, S., Moynagh, P. N., and Coogan, A. N. (2015). Lipopolysaccharide-induced sepsis induces long-lasting affective changes in the mouse. Brain Behav. Immun. 43, 98-109. doi:10.1016/j.bbi.2014.07.007
8. Andersson, U., and Tracey, K. J. (2011). HMGB1 is a therapeutic target for sterile inflammation and infection. Annu. Rev. Immunol. 29, 139-162. doi:10.1146/annurev-immunol-030409-101323
9. Andersson, U., and Tracey, K. J. (2012). Neural reflexes in inflammation and immunity. J. Exp. Med. 209, 1057-1068. doi:10.1084/jem.20120571
10. Appenzeller, S., Carnevalle, A. D., Li, L. M., Costallat, L. T., and Cendes, F. (2006). Hippocampal atrophy in systemic lupus erythematosus. Ann. Rheum. Dis. 65, 1585-1589. doi:10.1136/ard.2005.049486
11. Ascherio, A., and Marrie, R. A. (2012). Vitamin D in MS: A vitamin for 4 seasons. Neurology 79, 208-210. doi:10.1212/WNL.0b013e31825fe131
12. Azevedo, F. A., Carvalho, L. R., Grinberg, L. T., Farfel, J. M., Ferretti, R. E., Leite, R. E., et al. (2009). Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled-up primate brain. J. Comp. Neurol. 513, 532-541. doi:10.1002/cne.21974
13. Baker, M., Mackenzie, I. R., Pickering-Brown, S. M., Gass, J., Rademakers, R., Lind-holm, C., et al. (2006). Mutations in progranulin cause tau-negative frontotem-poral dementia linked to chromosome 17. Nature 442, 916-919. doi:10.1038/nj7102-596a
14. Baranzini, S. E., Srinivasan, R., Khankhanian, P., Okuda, D. T., Nelson, S. J., Matthews, P. M., et al. (2010). Genetic variation influences glutamate concentrations in brains of patients with multiple sclerosis. Brain 133, 2603-2611. doi:10.1093/brain/awq192
15. Barichello, T., Machado, R. A., Constantino, L., Valvassori, S. S., Reus, G. Z., Martins, M. R., et al. (2007). Antioxidant treatment prevented late memory impairment in an animal model of sepsis. Crit. Care Med. 35, 2186-2190. doi:10.1097/01.CCM.0000281452.60683.96
16. Barichello, T., Martins, M. R., Reinke, A., Feier, G., Ritter, C., Quevedo, J., et al. (2005). Cognitive impairment in sepsis survivors from cecal ligation and perforation. Crit. Care Med. 33, 221-223. doi:10.1097/01.CCM.0000150741.12906.BD
17. Barkhof, F., Calabresi, P. A., Miller, D. H., and Reingold, S. C. (2009). Imaging outcomes for neuroprotection and repair in multiple sclerosis trials. Nat. Rev. Neurol. 5, 256-266. doi:10.1038/nrneurol.2009.41
18. Belmont, H. M., Abramson, S. B., and Lie, J. T. (1996). Pathology and patho-genesis of vascular injury in systemic lupus erythematosus. Interactions of inflammatory cells and activated endothelium. Arthritis Rheum. 39, 9-22. doi:10.1002/art.1780390103
19. Ben Salem, C. (2013). The pathogenesis of the antiphospholipid syndrome. N. Engl. J. Med. 368, 2334. doi:10.1056/NEJMc1304515
20. Bennett, J. L., Lam, C., Kalluri, S. R., Saikali, P., Bautista, K., Dupree, C., et al. (2009). Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica. Ann. Neurol. 66, 617-629. doi:10.1002/ana.21802
21. Bernik, T. R., Friedman, S. G., Ochani, M., DiRaimo, R., Ulloa, L., Yang, H., et al. (2002). Pharmacological stimulation of the cholinergic antiinflammatory pathway. J. Exp. Med. 195, 781-788. doi:10.1084/jem.20011714
22. Bertram, L., Lange, C., Mullin, K., Parkinson, M., Hsiao, M., Hogan, M. F., et al. (2008). Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE. Am. J. Hum. Genet. 83, 623-632. doi:10.1016/j.ajhg.2008.10.008
23. Bianco, F., Pravettoni, E., Colombo, A., Schenk, U., Moller, T., Matteoli, M., et al. (2005). Astrocyte-derived ATP induces vesicle shedding and IL-1P release from microglia. J. Immunol. 174, 7268-7277. doi:10.4049/jimmunol.174.11.7268
24. Block, M. L., Zecca, L., and Hong, J. S. (2007). Microglia-mediated neurotox-icity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 8, 57-69. doi:10.1038/nrn2038
25. Bloom, O., Cheng, K. F., He, M., Papatheodorou, A., Volpe, B. T., Diamond, B., et al. (2011). Generation of a unique small molecule peptidomimetic that neutralizes lupus autoantibodyactivity. Proc. Natl. Acad. Sci. U.S.A. 108, 10255-10259. doi:10.1073/pnas.1103555108
26. B0, L., Vedeler, C. A., Nyland, H. I., Trapp, B. D., and M0rk, S. J. (2003). Subpial demyelination in the cerebral cortexofmultiple sclerosis patients. J. Neuropathol. Exp. Neurol. 62, 723-732.
27. Boardman, J. P., Counsell, S. J., Rueckert, D., Kapellou, O., Bhatia, K. K., Aljabar, P., et al. (2006). Abnormal deep grey matter development following preterm birth detected using deformation-based morphometry. Neuroimage 32, 70-78. doi:10.1016/j.neuroimage.2006.03.029
28. Boekstegers, P., Weidenhofer, S., Pilz, G., and Werdan, K. (1991). Peripheral oxygen availability within skeletal muscle in sepsis and septic shock: comparison to limited infection and cardiogenic shock. Infection 19, 317-323. doi:10.1007/BF01645355
29. Borovikova, L. V., Ivanova, S., Zhang, M., Yang, H., Botchkina, G. I., Watkins, L. R., et al. (2000). Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405, 458-462. doi:10.1038/35013070
30. Bradl, M., Misu, T., Takahashi, T., Watanabe, M., Mader, S., Reindl, M., et al. (2009). Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. Ann. Neurol. 66, 630-643. doi:10.1002/ana.21837
31. Bradshaw, E. M., Chibnik, L. B., Keenan, B. T., Ottoboni, L., Raj, T., Tang, A., et al. (2013). CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology. Nat. Neurosci. 16, 848-850. doi:10.1038/nn.3435
32. Braitenberg, V., and Schuz, A. (1991). Anatomyofthe Cortex:Statisticsand Geometry. Berlin: Springer-Verlag.
33. Bravo-Zehnder, M., Toledo, E. M., Segovia-Miranda, F., Serrano, F. G., Ben-ito, M. J., Metz, C., et al. (2015). Anti-ribosomal P protein autoantibodies from neuropsychiatric lupus impair memory. Arthritis Rheumatol. 67, 204-214. doi:10.1002/art.38900
34. Brealey, D., Brand, M., Hargreaves, I., Heales, S., Land, J., Smolenski, R., et al. (2002). Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 360, 219-223. doi:10.1016/S0140-6736(02)09459-X
35. Brosnan, C. F., and Raine, C. S. (2013). The astrocyte in multiple sclerosis revisited. Glia 61, 453-465. doi:10.1002/glia.22443
36. Bruck, W. (2005). The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage. J. Neurol. 252(Suppl. 5), v3-v9. doi:10.1007/s00415-005-5002-7
37. Bruck, W., and Stadelmann, C. (2003). Inflammation and degeneration in multiple sclerosis. Neurol. Sci. 24(Suppl. 5), S265-S267. doi:10.1007/s10072-003-0170-7
38. Brugg, B., Dubreuil, Y. L., Huber, G., Wollman, E. E., Delhaye-Bouchaud, N., and Mariani, J. (1995). Inflammatory processes induce beta-amyloid precursor protein changes in mouse brain. Proc. Natl. Acad. Sci. U.S.A. 92, 3032-3035. doi:10.1073/pnas.92.7.3032
39. Bullmore, E., and Sporns, O. (2009). Complex brain networks: graph theoretical analysis of structural and functional systems. Nat. Rev. Neurosci. 10, 186-198. doi:10.1038/nrn2575
40. Bullmore, E., and Sporns, O. (2012). The economy of brain network organization. Nat. Rev. Neurosci. 13, 336-349. doi:10.1038/nrn3214
41. Burger, D., Molnarfi, N., Weber, M. S., Brandt, K. J., Benkhoucha, M., Gruaz, L., et al. (2009). Glatiramer acetate increases IL-1 receptor antagonist but decreases T cell-induced IL-1beta in human monocytes and multiple sclerosis. Proc. Natl. Acad. Sci. U.S.A. 106, 4355-4359. doi:10.1073/pnas.0812183106
42. Burguillos, M. A., Deierborg, T., Kavanagh, E., Persson, A., Hajji, N., Garcia-Quintanilla, A., et al. (2011). Caspase signalling controls microglia activation and neurotoxicity. Nature 472, 319-324. doi:10.1038/nature09788
43. Capuron, L., Lamarque, D., Dantzer, R., and Goodall, G. (1999). Attentional and mnemonic deficits associated with infectious disease in humans. Psychol. Med. 29, 291-297. doi:10.1017/S0033291798007740
44. Capuron, L., Ravaud, A., and Dantzer, R. (2001). Timing and specificity of the cognitive changes induced by interleukin-2 and interferon-a treatments in cancer patients. Psychosom. Med. 63, 376-386. doi:10.1097/00006842-200105000-00007
45. Chavan, S. S., Huerta, P. T., Robbiati, S., Valdes-Ferrer, S. I., Ochani, M., Dancho, M., et al. (2012). HMGB1 mediates cognitive impairment in sepsis survivors. Mol. Med. 18, 930-937. doi:10.2119/molmed.2012.00195
46. Cheng, P. Y., Sham, A., and Kronstad, J. W. (2009). Cryptococcus gattii isolates from the British Columbia cryptococcosis outbreak induce less protective inflammation in a murine model of infection than Cryptococcus neoformans. Infect. Immun. 77, 4284-4294. doi:10.1128/IAI.00628-09
47. Chen-Plotkin, A. S., Xiao, J., Geser, F., Martinez-Lage, M., Grossman, M., Unger, T., et al. (2010). Brain progranulin expression in GRN-associated frontotemporal lobar degeneration. Acta Neuropathol. 119, 111-122. doi:10.1007/s00401-009-0576-2
48. Chiaravalloti, N. D., and DeLuca, J. (2008). Cognitive impairment in multiple sclerosis. Lancet Neurol. 7, 1139-1151. doi:10.1016/S1474-4422(08)70259-X
49. Chiu, I. M., Heesters, B. A., Ghasemlou, N., Von Hehn, C. A., Zhao, F., Tran, J., et al. (2013a). Bacteria activate sensory neurons that modulate pain and inflammation. Nature 501, 52-57. doi:10.1038/nature12479
50. Chiu, I. M., Morimoto, E. T., Goodarzi, H., Liao, J. T., O'Keeffe, S., Phatnani, H. P., et al. (2013b). Aneurodegeneration-specific gene-expression signature of acutely isolated microglia from an amyotrophic lateral sclerosis mouse model. Cell Rep. 4, 385-401. doi:10.1016/j.celrep.2013.06.018
51. Chiu, I. M., Phatnani, H., Kuligowski, M., Tapia, J. C., Carrasco, M. A., Zhang, M., et al. (2009). Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 106, 20960-20965. doi:10.1073/pnas.0911405106
52. Comim, C. M., Cassol-Jr, O. J., Constantino, L. S., Felisberto, F., Petronilho, F., Rezin, G. T., et al. (2011). Alterations in inflammatory mediators, oxidative stress parameters and energetic metabolism in the brain ofsepsis survivor rats. Neurochem. Res. 36, 304-311. doi:10.1007/s11064-010-0320-2
53. Compeyrot-Lacassagne, S., Tran, T. A., Guillaume-Czitrom, S., Marie, I., and Kone-Paut, I. (2009). Brain multiple sclerosis-like lesions in a patient with Muckle-Wells syndrome. Rheumatology (Oxford) 48, 1618-1619. doi:10.1093/rheumatology/kep321
54. Compston, A., and Coles, A. (2008). Multiple sclerosis. Lancet 372, 1502-1517. doi:10.1016/S0140-6736(08)61620-7
55. Confavreux, C., and Vukusic, S. (2006). Natural historyof multiple sclerosis: A unifying concept. Brain 129(Pt 3), 606-616. doi:10.1093/brain/awh714
56. Cooper, M. D., and Alder, M. N. (2006). The evolution ofadaptive immune systems. Cell 124, 815-822. doi:10.1016/j.cell.2006.02.001
57. Cree, B. (2008). Neuromyelitis optica: Diagnosis, pathogenesis, and treatment. Curr. Neurol. Neurosci. Rep. 8, 427-433. doi:10.1007/s11910-008-0066-2
58. Crow, Y. J., Hayward, B. E., Parmar, R., Robins, P., Leitch, A., Ali, M., et al. (2006). Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 cause Aicardi-Goutieres syndrome at the AGS1 locus. Nat. Genet. 38, 917-920. doi:10.1038/ng1845
59. Cunningham, C., Campion, S., Lunnon, K., Murray, C. L., Woods, J. F., Deacon, R. M., et al. (2009). Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease. Biol. Psychiatry 65, 304-312. doi:10.1016/j.biopsych.2008.07.024
60. Dalmau, J., Gleichman, A. J., Hughes, E. G., Rossi, J. E., Peng, X., Lai, M., et al. (2008). Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 7, 1091-1098. doi:10.1016/S1474-4422(08)70224-2
61. Dalmau, J., Lancaster, E., Martinez-Hernandez, E., Rosenfeld, M. R., and Balice-Gordon, R. (2011). Clinical experience and laboratoryinvestigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 10, 63-74. doi:10.1016/S1474-4422(10)70253-2
62. Dalmau, J., Tuzun, E., Wu, H. Y., Masjuan, J., Rossi, J. E., Voloschin, A., et al. (2007). Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann. Neurol. 61, 25-36. doi:10.1002/ana.21050
63. Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., and Kelley, K. W. (2008). From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 9, 46-56. doi:10.1038/nrn2297
64. d'Avila, J. C., Santiago, A. P., Amancio, R. T., Galina, A., Oliveira, M. F., and Bozza, F. A. (2008). Sepsis induces brain mitochondrial dysfunction. Crit. Care Med. 36, 1925-1932. doi:10.1097/CCM.0b013e3181760c4b
65. Dawson, V. L., Dawson, T. M., Bartley, D. A., Uhl, G. R., and Snyder, S. H. (1993). Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J. Neurosci 13, 2651-2661.
66. De Stefano, N., Narayanan, S., Francis, G. S., Arnaoutelis, R., Tartaglia, M. C., Antel, J. P., et al. (2001). Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. Arch. Neurol. 58, 65-70. doi:10.1001/archneur.58.1.65
67. de Vries, B., Steup-Beekman, G. M., Haan, J., Bollen, E. L., Luyendijk, J., Frants, R. R., et al. (2010). TREX1 gene variant in neuropsychiatric systemic lupus erythematosus. Ann. Rheum. Dis. 69, 1886-1887. doi:10.1136/ard.2009.114157
68. DeGiorgio, L. A., Konstantinov, K. N., Lee, S. C., Hardin, J. A., Volpe, B. T., and Diamond, B. (2001). A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat. Med. 7, 1189-1193. doi:10.1038/nm1101-1189
69. DeLuca, G. C., Alterman, R., Martin, J. L., Mittal, A., Blundell, S., Bird, S., et al. (2013). Casting light on multiple sclerosis heterogeneity: the role of HLA-DRB1 on spinal cord pathology. Brain 136(Pt 4), 1025-1034. doi:10.1093/brain/awt031
70. Deutschman, C. S., and Tracey, K. J. (2014). Sepsis: current dogma and new perspectives. Immunity 40, 463-475. doi:10.1016/j.immuni.2014.04.001
71. Diamond, B., Honig, G., Mader, S., Brimberg, L., and Volpe, B. T. (2013). Brain-reactive antibodies and disease. Annu. Rev. Immunol. 31, 345-385. doi:10.1146/annurev-immunol-020711-075041
72. Ebers, G. C., Sadovnick, A. D., and Risch, N. J. (1995). A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group. Nature 377, 150-151. doi:10.1038/377150a0
73. Eidelman, L. A., Putterman, D., Putterman, C., and Sprung, C. L. (1996). The spectrum of septic encephalopathy. Definitions, etiologies, and mortalities. JAMA 275, 470-473. doi:10.1001/jama.1996.03530300054040
74. Ekdahl, C. T., Claasen, J. H., Bonde, S., Kokaia, Z., and Lindvall, O. (2003). Inflammation is detrimental for neurogenesis in adult brain. Proc. Natl. Acad. Sci. U.S.A. 100, 13632-13637. doi:10.1073/pnas.2234031100
75. Ely, E. W., Gautam, S., Margolin, R., Francis, J., May, L., Speroff, T., et al. (2001). The impact of delirium in the intensive care unit on hospital length of stay. Intensive Care Med. 27, 1892-1900. doi:10.1007/s00134-001-1132-2
76. Ely, E. W., Shintani, A., Truman, B., Speroff, T., Gordon, S. M., Harrell, F. E. Jr., et al. (2004). Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA291, 1753-1762. doi:10.1001/jama.291.14.1753
77. Epel, E. S., Blackburn, E. H., Lin, J., Dhabhar, F. S., Adler, N. E., Morrow, J. D., et al. (2004). Accelerated telomere shortening in response to life stress. Proc. Natl. Acad. Sci. U.S.A. 101, 17312-17315. doi:10.1073/pnas.0407162101
78. Faust, T. W., Chang, E. H., Kowal, C., Berlin, R., Gazaryan, I. G., Bertini, E., et al. (2010). Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms. Proc. Natl. Acad. Sci. U.S.A. 107, 18569-18574. doi:10.1073/pnas.1006980107
79. Fischer, M. T., Sharma, R., Lim, J. L., Haider, L., Frischer, J. M., Drexhage, J., et al. (2012). NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury. Brain 135(Pt 3), 886-899. doi:10.1093/brain/aws012
80. Forton, D. M., Allsop, J. M., Main, J., Foster, G. R., Thomas, H. C., and Taylor-Robinson, S. D. (2001). Evidence for a cerebral effect of the hepatitis C virus. Lancet 358, 38-39. doi:10.1016/S0140-6736(01)07051-9
81. Forton, D. M., Thomas, H. C., Murphy, C. A., Allsop, J. M., Foster, G. R., Main, J., et al. (2002). Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology 35, 433-439. doi:10.1053/jhep.2002.30688
82. Frakes, A. E., Ferraiuolo, L., Haidet-Phillips, A. M., Schmelzer, L., Braun, L., Miranda, C. J., et al. (2014). Microglia induce motor neuron death via the classical NF-kB pathway in amyotrophic lateral sclerosis. Neuron 81, 1009-1023. doi:10.1016/j.neuron.2014.01.013
83. Friedlander, R. M. (2003). Apoptosis and caspases in neurodegenerative diseases. N. Engl. J. Med. 348, 1365-1375. doi:10.1056/NEJMra022366
84. Friese, M. A., Montalban, X., Willcox, N., Bell, J. I., Martin, R., and Fugger, L. (2006). The value of animal models for drug development in multiple sclerosis. Brain 129(Pt 8), 1940-1952. doi:10.1093/brain/awl083
85. Friese, M. A., Schattling, B., and Fugger, L. (2014). Mechanisms of neurodegenera-tion and axonal dysfunction in multiple sclerosis. Nat. Rev. Neurol. 10, 225-238. doi:10.1038/nrneurol.2014.37
86. Frischer, J. M., Bramow, S., Dal-Bianco, A., Lucchinetti, C. F., Rauschka, H., Schmid-bauer, M., et al. (2009). The relation between inflammation and neurodegenera-tion in multiple sclerosis brains. Brain 132(Pt 5), 1175-1189. doi:10.1093/brain/awp070
87. Fu, H. Q., Yang, T., Xiao, W., Fan, L., Wu, Y., Terrando, N., et al. (2014). Prolonged neuroinflammation after lipopolysaccharide exposure in aged rats. PLoS ONE 9:e106331. doi:10.1371/journal.pone.0106331
88. Funfschilling, U., Supplie, L. M., Mahad, D., Boretius, S., Saab, A. S., Edgar, J., et al. (2012). Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature 485, 517-521. doi:10.1038/nature11007
89. Gaynor, B., Putterman, C., Valadon, P., Spatz, L., Scharff, M. D., and Diamond, B. (1997). Peptide inhibition of glomerular deposition of an anti-DNA antibody. Proc. Natl. Acad. Sci. U.S.A. 94, 1955-1960. doi:10.1073/pnas.94.5.1955
90. Geurts, J. J., Bo, L., Roosendaal, S. D., Hazes, T., Daniels, R., Barkhof, F., et al. (2007). Extensive hippocampal demyelination in multiple sclerosis. J. Neuropathol. Exp. Neurol. 66, 819-827. doi:10.1097/nen.0b013e3181461f54
91. Ghadge, G. D., Lee, J. P., Bindokas, V. P., Jordan, J., Ma, L., Miller, R. J., et al. (1997). Mutant superoxide dismutase-1-linked familial amyotrophic lateral sclerosis: molecular mechanisms of neuronal death and protection. J. Neurosci. 17, 8756-8766.
92. Giannakopoulos, B., and Krilis, S. A. (2013). The pathogenesis of the antiphospholipid syndrome. N. Engl. J. Med. 368, 1033-1044. doi:10.1056/NEJMra1112830
93. Giuliani, F., Goodyer, C. G., Antel, J. P., and Yong, V. W. (2003). Vulnerability of human neurons to T cell-mediated cytotoxicity. J. Immunol. 171, 368-379. doi:10.4049/jimmunol.171.1.368
94. Gofton, T. E., and Young, G. B. (2012). Sepsis-associated encephalopathy. Nat. Rev. Neurol. 8, 557-566. doi:10.1038/nrneurol.2012.183
95. Gomez-Puerta, J. A., Cervera, R., Calvo, L. M., Gomez-Anson, B., Espinosa, G., Claver, G., et al. (2005). Dementia associated with the antiphospholipid syndrome: clinical and radiological characteristics of 30 patients. Rheumatology (Oxford) 44, 95-99. doi:10.1093/rheumatology/keh408
96. Graham, A. L., Allen, J. E., and Read, A. F. (2005). Evolutionary causes and consequences of immunopathology. Annu. Rev. Ecol. Evol. Syst. 36, 373-397. doi:10.1146/annurev.ecolsys.36.102003.152622
97. Green, D. R., Ferguson, T., Zitvogel, L., and Kroemer, G. (2009). Immunogenic and tolerogenic cell death. Nat. Rev. Immunol. 9, 353-363. doi:10.1038/nri2545
98. Green, D. R., and Kroemer, G. (2004). The pathophysiology of mitochondrial cell death. Science 305, 626-629. doi:10.1126/science.1099320
99. Greenlund, L. J., Deckwerth, T. L., and Johnson, E. M. Jr. (1995). Superoxide dismu-tase delays neuronal apoptosis: arole for reactive oxygen species in programmed neuronal death. Neuron 14, 303-315. doi:10.1016/0896-6273(95)90287-2
100. Gregory, A. P., Dendrou, C. A., Attfield, K. E., Haghikia, A., Xifara, D. K., Butter, F., et al. (2012). TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis. Nature 488, 508-511. doi:10.1038/nature11307
101. Griciuc, A., Serrano-Pozo, A., Parrado, A. R., Lesinski, A. N., Asselin, C. N., Mullin, K., et al. (2013). Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron 78, 631-643. doi:10.1016/j.neuron.2013.04.014
102. Gris, D., Ye, Z., Iocca, H. A., Wen, H., Craven, R. R., Gris, P., et al. (2010). NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses. J. Immunol. 185, 974-981. doi:10.4049/jimmunol.0904145
103. Guarda, G., Braun, M., Staehli, F., Tardivel, A., Mattmann, C., Forster, I., et al. (2011). Type I interferon inhibits interleukin-1 production and inflammasome activation. Immunity 34, 213-223. doi:10.1016/j.immuni.2011.02.006
104. Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., et al. (2013). TREM2 variants in Alzheimer's disease. N. Engl. J. Med. 368, 117-127. doi:10.1056/NEJMoa1211851
105. Gulinelli, S., Salaro, E., Vuerich, M., Bozzato, D., Pizzirani, C., Bolognesi, G., et al. (2012). IL-18 associates to microvesicles shed from human macrophages by a LPS/TLR-4 independent mechanism in response to P2X receptor stimulation. Eur. J. Immunol. 42, 3334-3345. doi:10.1002/eji.201142268
106. Hadjivassiliou, M., Aeschlimann, P., Sanders, D. S., Maki, M., Kaukinen, K., Grunewald, R. A., et al. (2013). Transglutaminase 6 antibodies in the diagnosis of gluten ataxia. Neurology 80, 1740-1745. doi:10.1212/WNL.0b013e3182919070
107. Hanly, J. G., Walsh, N. M., and Sangalang, V. (1992). Brain pathology in systemic lupus erythematosus. J. Rheumatol. 19, 732-741.
108. Hauser, S. L., Waubant, E., Arnold, D. L., Vollmer, T., Antel, J., Fox, R. J., et al. (2008). B-celldepletion withrituximab in relapsing-remittingmultiple sclerosis. N. Engl. J. Med. 358, 676-688. doi:10.1056/NEJMoa0706383
109. Hauser, W., Janke, K. H., Klump, B., and Hinz, A. (2011). Anxiety and depression in patients with inflammatory bowel disease: comparisons with chronic liver disease patients and the general population. Inflamm. Bowel Dis. 17, 621-632. doi:10.1002/ibd.21346
110. Heneka, M. T., Kummer, M. P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., et al. (2013). NLRP3 is activated in Alzheimer's disease and contributes to pathologyin APP/PS1 mice. Nature 493, 674-678. doi:10.1038/nature11729
111. Hilsabeck, R. C., Perry, W., and Hassanein, T. I. (2002). Neuropsychological impairment in patients with chronic hepatitis C. Hepatology 35, 440-446. doi:10.1053/jhep.2002.31257
112. Hockenbery, D. M., Oltvai, Z. N., Yin, X. M., Milliman, C. L., and Korsmeyer, S. J. (1993). Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75, 241-251. doi:10.1016/0092-8674(93)80066-N
113. Holmes, C., Cunningham, C., Zotova, E., Woolford, J., Dean, C., Kerr, S., et al. (2009). Systemic inflammation and disease progression in Alzheimer disease. Neurology 73, 768-774. doi:10.1212/WNL.0b013e3181b6bb95
114. Hu, S., Rotschafer, J. H., Lokensgard, J. R., and Cheeran, M. C. (2014). Activated CD8+ T lymphocytes inhibit neural stem/progenitor cell proliferation: role of interferon-gamma. PLoS ONE 9:e105219. doi:10.1371/journal.pone.0105219
115. Hughes, E. G., Peng, X., Gleichman, A. J., Lai, M., Zhou, L., Tsou, R., et al. (2010). Cellular and synaptic mechanisms ofanti-NMDAreceptor encephalitis. J. Neurosci. 30, 5866-5875. doi:10.1523/JNEUROSCI.0167-10.2010
116. International Parkinson Disease Genomics Consortium, Nalls, M. A., Plagnol, V., Hernandez, D. G., Sharma, M., Sheerin, U. M., et al. (2011). Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet 377, 641-649. doi:10.1016/S0140-6736(10)62345-8
117. Iwashyna, T. J., Cooke, C. R., Wunsch, H., and Kahn, J. M. (2012). Population burden of long-term survivorship after severe sepsis in older Americans. J. Am. Geriatr. Soc. 60, 1070-1077. doi:10.1111/j.1532-5415.2012.03989.x
118. Iwashyna, T. J., Ely, E. W., Smith, D. M., and Langa, K. M. (2010). Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA304, 1787-1794. doi:10.1001/jama.2010.1553
119. Jeltsch-David, H., and Muller, S. (2014). Neuropsychiatric systemic lupus ery-thematosus: pathogenesis and biomarkers. Nat. Rev. Neurol. 10, 579-596. doi:10.1038/nrneurol.2014.148
120. Ji, H., Rabbi, M. F., Labis, B., Pavlov, V. A., Tracey, K. J., and Ghia, J. E. (2014). Central cholinergic activation of a vagus nerve-to-spleen circuit alleviates experimental colitis. Mucosal Immunol. 7, 335-347. doi:10.1038/mi.2013.52
121. Jin, K., Wang, X., Xie, L., Mao, X. O., Zhu, W., Wang, Y., et al. (2006a). Evidence for stroke-induced neurogenesis in the human brain. Proc. Natl. Acad. Sci. U.S.A. 103, 13198-13202. doi:10.1073/pnas.0601164103
122. Jin, K., Xie, L., Mao, X. O., and Greenberg, D. A. (2006b). Alzheimer's disease drugs promote neurogenesis. Brain Res. 1085, 183-188. doi:10.1016/j.brainres.2006.02.081
123. Johansson, J. U., Woodling, N. S., Wang, Q., Panchal, M., Liang, X., Trueba-Saiz, A., et al. (2015). Prostaglandin signaling suppresses beneficial microglial function in Alzheimer's disease models. J. Clin. Invest. 125, 350-364. doi:10.1172/JCI77487
124. Jones, J. D. G., and Dangl, J. L. (2006). The plant immune system. Nature 444, 323-329. doi:10.1038/nature05286
125. Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., et al. (2013). Variant of TREM2 associated with the risk of Alzheimer's disease. N. Engl. J. Med. 368, 107-116. doi:10.1056/NEJMoa1211103
126. Joshi, P., Turola, E., Ruiz, A., Bergami, A., Libera, D. D., Benussi, L., et al. (2014). Microglia convert aggregated amyloid-[beta] into neurotoxic forms through the shedding of microvesicles. Cell Death Differ. 21, 582-593. doi:10.1038/cdd.2013.180
127. Kaur, C., Sivakumar, V., Zou, Z., and Ling, E. A. (2014). Microglia-derived proin-flammatory cytokines tumor necrosis factor-alpha and interleukin-1beta induce Purkinje neuronal apoptosis via their receptors in hypoxic neonatal rat brain. Brain Struct. Funct. 219, 151-170. doi:10.1007/s00429-012-0491-5
128. Khanna, K. M., Lepisto, A. J., Decman, V., and Hendricks, R. L. (2004). Immune control of herpes simplex virus during latency. Curr. Opin. Immunol. 16, 463-469. doi:10.1016/j.coi.2004.05.003
129. Kiecolt-Glaser, J. K., Dura, J. R., Speicher, C. E., Trask, O. J., and Glaser, R. (1991). Spousal caregivers of dementia victims: longitudinal changes in immunity and health. Psychosom. Med. 53, 345-362. doi:10.1097/00006842-199107000-00001
130. Kiecolt-Glaser, J. K., Glaser, R., Shuttleworth, E. C., Dyer, C. S., Ogrocki, P., and Speicher, C. E. (1987). Chronic stress and immunity in family caregivers of Alzheimer's disease victims. Psychosom. Med. 49, 523-535. doi:10.1097/00006842-198709000-00008
131. Kinoshita, M., Nakatsuji, Y., Kimura, T., Moriya, M., Takata, K., Okuno, T., et al. (2009). Neuromyelitis optica: passive transfer to ratsbyhumanimmunoglobulin. Biochem. Biophys. Res. Commun. 386, 623-627. doi:10.1016/j.bbrc.2009.06.085
132. Kleinberger, G., Yamanishi, Y., Suarez-Calvet, M., Czirr, E., Lohmann, E., Cuyvers, E., et al. (2014). TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis. Sci. Transl. Med. 6, 243-286. doi:10.1126/scitranslmed.3009093
133. Knoll, A. H., Walter, M. R., Narbonne, G. M., and Christie-Blick, N. (2004). A new period for the geologic time scale. Science 305, 621-622. doi:10.1126/science.1098803
134. Kotani, S., Yamauchi, T., Teramoto, T., and Ogura, H. (2008). Donepezil, an acetyl-cholinesterase inhibitor, enhances adult hippocampal neurogenesis. Chem. Biol. Interact. 175, 227-230. doi:10.1016/j.cbi.2008.04.004
135. Kowal, C., Degiorgio, L. A., Lee, J. Y., Edgar, M. A., Huerta, P. T., Volpe, B. T., etal. (2006). Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc. Natl. Acad. Sci. U.S.A. 103, 19854-19859. doi:10.1073/pnas.0608397104
136. Krumbholz, M., Derfuss, T., Hohlfeld, R., and Meinl, E. (2012). B cells and antibodies in multiple sclerosis pathogenesis and therapy. Nat. Rev. Neurol. 8, 613-623. doi:10.1038/nrneurol.2012.203
137. Kuerten, S., Pommerschein, G., Barth, S. K., Hohmann, C., Milles, B., Sammer, F. W., et al. (2014). Identification of a B cell-dependent subpopulation of multiple sclerosis bymeasurements of brain-reactive B cells in the blood. Clin. Immunol. 152, 20-24. doi:10.1016/j.clim.2014.02.014
138. Kuhle, J., Leppert, D., Petzold, A., Regeniter, A., Schindler, C., Mehling, M., etal. (2011). Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis. Neurology 76, 1206-1213. doi:10.1212/WNL.0b013e31821432ff
139. Kutzelnigg, A., Faber-Rod, J. C., Bauer, J., Lucchinetti, C. F., Sorensen, P. S., Laursen, H., et al. (2007). Widespread demyelination in the cerebellar cortex in multiple sclerosis. Brain Pathol. 17, 38-44. doi:10.1111/j.1750-3639.2006.00041.x
140. Kutzelnigg, A., Lucchinetti, C. F., Stadelmann, C., Bruck, W., Rauschka, H., Bergmann, M., et al. (2005). Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 128(Pt 11), 2705-2712. doi:10.1093/brain/awh641
141. Lambert, J. C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., et al. (2009). Genome-wide association study identifies variants at CLUand CR1 associated with Alzheimer's disease. Nat. Genet. 41, 1094-1099. doi:10.1038/ng.439
142. Lancaster, E., and Dalmau, J. (2012). Neuronal autoantigens - pathogenesis, associated disorders and antibody testing. Nat. Rev. Neurol. 8, 380-390. doi:10.1038/nrneurol.2012.99
143. Lassmann, H. (2011). Mechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer's disease. J. Neural Transm. 118, 747-752. doi:10.1007/s00702-011-0607-8
144. Lassmann, H., Bruck, W., and Lucchinetti, C. F. (2007). The immunopathology of multiple sclerosis: an overview. Brain Pathol. 17, 210-218. doi:10.1111/j.1750-3639.2007.00064.x
145. Lassmann, H., van Horssen, J., and Mahad, D. (2012). Progressive multiple sclerosis: pathologyand pathogenesis. Nat. Rev. Neurol. 8, 647-656. doi:10.1038/nrneurol.2012.168
146. Latora, V., and Marchiori, M. (2001). Efficient behavior of small-world networks. Phys. Rev. Lett. 87, 198701. doi:10.1103/PhysRevLett.87.198701
147. Lazarov, O., and Marr, R. A. (2010). Neurogenesis and Alzheimer's disease: At the crossroads. Exp. Neurol. 223, 267-281. doi:10.1016/j.expneurol.2009.08.009
148. Lee, Y., Morrison, B. M., Li, Y., Lengacher, S., Farah, M. H., Hoffman, P. N., et al. (2012). Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature 487, 443-448. doi:10.1038/nature11314
149. Lee-Kirsch, M. A., Chowdhury, D., Harvey, S., Gong, M., Senenko, L., Engel, K., et al. (2007a). A mutation in TREX1 that impairs susceptibility to granzyme A-mediated cell death underlies familial chilblain lupus. J. Mol. Med. (Berl.) 85, 531-537. doi:10.1007/s00109-007-0199-9
150. Lee-Kirsch, M. A., Gong, M., Chowdhury, D., Senenko, L., Engel, K., Lee, Y. A., et al. (2007b). Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat. Genet. 39, 1065-1067. doi:10.1038/ng2091
151. Lemcke, S., Muller, S., Moller, S., Schillert, A., Ziegler, A., Cepok-Kauffeld, S., et al. (2014). Nerve conduction velocityis regulated bythe inositol polyphosphate-4-phosphatase II gene. Am. J. Pathol. 184, 2420-2429. doi:10.1016/j.ajpath.2014.05.021
152. Lemstra, A. W., Groenin'tWoud, J. C., Hoozemans, J. J., van Haastert, E. S., Rozemuller, A. J., Eikelenboom, P., et al. (2007). Microglia activation in sepsis: a case-control study. J. Neuroinflammation 15, 4.
153. Lennon, V. A., Kryzer, T. J., Pittock, S. J., Verkman, A. S., and Hinson, S. R. (2005). IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J. Exp. Med. 202, 473-477. doi:10.1084/jem.20050304
154. Levy, M. (2014). Does aquaporin-4-seronegative neuromyelitis optica exist? JAMA Neurol. 71, 271-272. doi:10.1001/jamaneurol.2013.5865
155. Li, Z., Ma, L., Kulesskaya, N., Voikar, V., and Tian, L. (2014). Microglia are polarized to M1 type in high-anxiety inbred mice in response to lipopolysaccharide challenge. Brain Behav. Immun. 38, 237-248. doi:10.1016/j.bbi.2014.02.008
156. Liang, X., Wang, Q., Hand, T., Wu, L., Breyer, R. M., Montine, T. J., et al. (2005). Deletion of the prostaglandin E2 EP2 receptor reduces oxidative damage and amyloid burden in a model ofAlzheimer's disease. J. Neurosci. 25, 10180-10187. doi:10.1523/JNEUROSCI.3591-05.2005
157. Lin, M. T., and Beal, M. F. (2006). Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443, 787-795. doi:10.1038/nature05292
158. Liu, B., and Hong, J. S. (2003). Role of microglia in inflammation-mediated neu-rodegenerative diseases: mechanisms and strategies for therapeutic intervention. J. Pharmacol. Exp. Ther. 304, 1-7. doi:10.1124/jpet.102.043406
159. Lu, T., Pan, Y., Kao, S. Y., Li, C., Kohane, I., Chan, J., et al. (2004). Gene regulation and DNA damage in the ageing human brain. Nature 429, 883-891. doi:10.1038/nature02661
160. Lucchinetti, C., Bruck, W., Parisi, J., Scheithauer, B., Rodriguez, M., and Lass-mann, H. (2000). Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis ofdemyelination. Ann. Neurol. 47, 707-717. doi:10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q
161. Lucchinetti, C. F., Mandler, R. N., McGavern, D., Bruck, W., Gleich, G., Ransohoff, R. M., et al. (2002). A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 125(Pt 7), 1450-1461. doi:10.1093/brain/awf151
162. Lucchinetti, C. F., Popescu, B. F., Bunyan, R. F., Moll, N. M., Roemer, S. F., Lassmann, H., et al. (2011). Inflammatory cortical demyelination in early multiple sclerosis. N. Engl. J. Med. 365, 2188-2197. doi:10.1056/NEJMoa1100648
163. Mader, S., Lutterotti, A., Di Pauli, F., Kuenz, B., Schanda, K., Aboul-Enein, F., et al. (2010). Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica. PLoS ONE 5:e10455. doi:10.1371/journal.pone.0010455
164. Mak, A., Cheung, M. W., Chiew, H. J., Liu, Y., and Ho, R. C. (2012). Global trend of survival and damage of systemic lupus erythematosus: meta-analysis and meta-regression of observational studies from the 1950s to 2000s. Semin. Arthritis Rheum. 41, 830-839. doi:10.1016/j.semarthrit.2011.11.002
165. Malberg, J. E., Eisch, A. J., Nestler, E. J., and Duman, R. S. (2000). Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J. Neurosci. 20, 9104-9110.
166. Martens, L. H., Zhang, J., Barmada, S. J., Zhou, P., Kamiya, S., Sun, B., et al. (2012). Progranulin deficiency promotes neuroinflammation and neuron loss following toxin-induced injury. J. Clin. Invest. 122, 3955-3959. doi:10.1172/JCI63113
167. Martinon, F., Burns, K., and Tschopp, J. (2002). The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol. Cell 10, 417-426. doi:10.1016/S1097-2765(02)00599-3
168. Martinon, F., and Tschopp, J. (2004). Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 117, 561-574. doi:10.1016/j.cell.2004.05.004
169. Matiello, M., Lennon, V. A., Jacob, A., Pittock, S. J., Lucchinetti, C. F., Wingerchuk, D. M., et al. (2008). NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology 70, 2197-2200. doi:10.1212/01.wnl.0000303817.82134.da
170. Matsuki, T., Nakae, S., Sudo, K., Horai, R., and Iwakura, Y. (2006). Abnormal T cell activation caused bythe imbalance ofthe IL-1/IL-1Rantagonistsystemis responsible for the development of experimental autoimmune encephalomyelitis. Int. Immunol. 18, 399-407. doi:10.1093/intimm/dxh379
171. McColl, B. W., Rothwell, N. J., and Allan, S. M. (2008). Systemic inflammation alters the kinetics of cerebrovascular tight junction disruption after experimental stroke in mice. J. Neurosci. 28, 9451-9462. doi:10.1523/JNEUROSCI.2674-08.2008
172. McFarland, H. F., and Martin, R. (2007). Multiple sclerosis: A complicated picture of autoimmunity. Nat. Immunol. 8, 913-919. doi:10.1038/ni1507
173. McNicoll, L., Pisani, M. A., Zhang, Y., Ely, E. W., Siegel, M. D., and Inouye, S. K. (2003). Delirium in the intensive care unit: Occurrence and clinical course in older patients. J. Am. Geriatr. Soc. 51, 591-598. doi:10.1034/j.1600-0579.2003.00201.x
174. Medzhitov, R., and Janeway, C. A. (1997). Innate immunity: The virtues of a nonclonal system of recognition. Cell 91, 295-298. doi:10.1016/S0092-8674(00)80412-2
175. Medzhitov, R., Schneider, D. S., and Soares, M. P. (2012). Disease tolerance as a defense strategy. Science 335, 936-941. doi:10.1126/science.1214935
176. Michels, M., Vieira, A. S., Vuolo, F., Zapelini, H. G., Mendonca, B., Mina, F., et al. (2015). The role of microglia activation in the development of sepsis-induced long-term cognitive impairment. Brain Behav. Immun. 43, 54-59. doi:10.1016/j.bbi.2014.07.002
177. Miller, D. H., and Leary, S. M. (2007). Primary-progressive multiple sclerosis. Lancet Neurol. 6, 903-912. doi:10.1016/S1474-4422(07)70213-2
178. Million, M., and Raoult, D. (2013). The pathogenesis of the antiphospholipid syndrome. N. Engl. J. Med. 368, 2335. doi:10.1056/NEJMc1300484
179. Mina-Osorio, P., Rosas-Ballina, M., Valdes-Ferrer, S. I., Al-Abed, Y., Tracey, K. J., and Diamond, B. (2012). Neural signaling in the spleen controls B-cell responses to blood-borne antigen. Mol. Med. 18, 618-627. doi:10.2119/molmed.2012.00027
180. Miner, J. J., and Diamond, M. S. (2014). MDA5 and autoimmune disease. Nat. Genet. 46, 418-419. doi:10.1038/ng.2959
181. Monje, M. L., Toda, H., and Palmer, T. D. (2003). Inflammatory blockade restores adult hippocampal neurogenesis. Science 302, 1760-1765. doi:10.1126/science.1088417
182. Montine, T. J., Sidell, K. R., Crews, B. C., Markesbery, W. R., Marnett, L. J., Roberts, L. J. II, et al. (1999). Elevated CSF prostaglandin E2 levels in patients with probable AD. Neurology 53, 1495-1495. doi:10.1212/WNL.53.7.1495
183. Morandi, A., Rogers, B. P., Gunther, M. L., Merkle, K., Pandharipande, P., Girard, T. D., et al. (2012). The relationship between delirium duration, white matter integrity, and cognitive impairment in intensive care unit survivors as determined by diffusion tensor imaging: the VISIONS prospective cohort magnetic resonance imaging study. Crit. Care Med. 40, 2182-2189. doi:10.1097/CCM.0b013e318250acdc
184. Moresco, E. M. Y., LaVine, D., and Beutler, B. (2011). Toll-like receptors. Curr. Biol. 21, R488-R493. doi:10.1016/j.cub.2011.05.039
185. Morita, M., Stamp, G., Robins, P., Dulic, A., Rosewell, I., Hrivnak, G., et al. (2004). Gene-targeted mice lacking the Trex1 (DNase III) 3' - >5' DNA exonuclease develop inflammatory myocarditis. Mol. Cell. Biol. 24, 6719-6727. doi:10.1128/MCB.24.22.9736-9743.2004
186. Murray, C., Sanderson, D. J., Barkus, C., Deacon, R. M., Rawlins, J. N., Bannerman, D. M., et al. (2012). Systemic inflammation induces acute working memory deficits in the primed brain: relevance for delirium. Neurobiol. Aging 33, 603-616. doi:10.1016/j.neurobiolaging.2010.04.002
187. Neumann, H. (2001). Control of glial immune function by neurons. Glia 36, 191-199. doi:10.1002/glia.1108
188. Neumann, H., Medana, I. M., Bauer, J., and Lassmann, H. (2002). Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases. Trends Neurosci. 25, 313-319. doi:10.1016/S0166-2236(02)02154-9
189. Nguyen, M. D., D'Aigle, T., Gowing, G., Julien, J. P., and Rivest, S. (2004). Exacerbation of motor neuron disease by chronic stimulation of innate immunity in a mouse model of amyotrophic lateral sclerosis. J. Neurosci. 24, 1340-1349. doi:10.1523/JNEUROSCI.4786-03.2004
190. Nitsch, R., Pohl, E. E., Smorodchenko, A., Infante-Duarte, C., Aktas, O., and Zipp, F. (2004). Direct impact ofT cells on neurons revealed bytwo-photon microscopy in livingbrain tissue. J. Neurosci. 24, 2458-2464. doi:10.1523/JNEUROSCI.4703-03.2004
191. Noh, H., Jeon, J., and Seo, H. (2014). Systemic injection of LPS induces region-specific neuroinflammation and mitochondrial dysfunction in normal mouse brain. Neurochem. Int. 69, 35-40. doi:10.1016/j.neuint.2014.02.008
192. Noseworthy, J. H., Lucchinetti, C., Rodriguez, M., and Weinshenker, B. G. (2000). Multiple sclerosis. N. Engl. J. Med. 343, 938-952. doi:10.1056/NEJM200009283431307
193. Ousman, S. S., and Kubes, P. (2012). Immune surveillance in the central nervous system. Nat. Neurosci. 15, 1096-1101. doi:10.1038/nn.3161
194. Palace, J., Leite, M. I., Nairne, A., and Vincent, A. (2010). Interferon betatreatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibodytiters. Arch. Neurol. 67, 1016-1017. doi:10.1001/archneurol.2010.188
195. Paloneva, J., Kestila, M., Wu, J., Salminen, A., Bohling, T., Ruotsalainen, V., et al. (2000). Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts. Nat. Genet. 25, 357-361. doi:10.1038/77153
196. Paloneva, J., Manninen, T., Christman, G., Hovanes, K., Mandelin, J., Adolfsson, R., et al. (2002). Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype. Am. J. Hum. Genet. 71, 656-662. doi:10.1086/342259
197. Papadopoulos, M. C., Bennett, J. L., and Verkman, A. S. (2014). Treatment of neu-romyelitis optica: state-of-the-art and emerging therapies. Nat. Rev. Neurol. 10, 493-506. doi:10.1038/nrneurol.2014.141
198. Papathanasiou, A., Nikakis, P., Bonakis, A., Kilidireas, K., Dimitrakopoulos, A., Michopoulos, S., et al. (2014). Rapidly progressive dementia as presenting feature in inflammatory bowel disease. Alzheimer Dis. Assoc. Disord. 28, 294-295. doi:10.1097/WAD.0b013e31826a96b2
199. Park, L., Zhou, J., Zhou, P., Pistick, R., El Jamal, S., Younkin, L., et al. (2013). Innate immunity receptor CD36 promotes cerebral amyloid angiopathy. Proc. Natl. Acad. Sci. U.S.A. 110, 3089-3094. doi:10.1073/pnas.1300021110
200. Parkhurst, C. N., Yang, G., Ninan, I., Savas, J. N., Yates, J. R. III, Lafaille, J. J., et al. (2013). Microgliapromote learning-dependent synapse formation through brain-derived neurotrophic factor. Cell 155, 1596-1609. doi:10.1016/j.cell.2013.11.030
201. Pasinelli, P., Borchelt, D. R., Houseweart, M. K., Cleveland, D. W., and Brown, R. H. Jr. (1998). Caspase-1 is activated in neural cells and tissue with amyotrophic lateral sclerosis-associated mutations in copper-zinc superoxide dismutase. Proc. Natl. Acad. Sci. U.S.A. 95, 15763-15768. doi:10.1073/pnas.95.26.15763
202. Pavlov, V. A., Parrish, W. R., Rosas-Ballina, M., Ochani, M., Puerta, M., Ochani, K., et al. (2009). Brain acetylcholinesterase activitycontrols systemic cytokine levels through the cholinergic anti-inflammatory pathway. Brain Behav. Immun. 23, 41-45. doi:10.1016/j.bbi.2008.06.011
203. Peterson, J. W., Bo, L., Mork, S., Chang, A., and Trapp, B. D. (2001). Transected neu-rites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann. Neurol. 50, 389-400. doi:10.1002/ana.1123
204. Pickford, F., Marcus, J., Camargo, L. M., Xiao, Q., Graham, D., Mo, J. R., et al. (2011). Progranulin is a chemoattractant for microglia and stimulates their endocytic activity. Am. J. Pathol. 178, 284-295. doi:10.1016/j.ajpath.2010.11.002
205. Pohl, M., Kawakami, N., Kitic, M., Bauer, J., Martins, R., Fischer, M. T., et al. (2013). Tcell-activation in neuromyelitis optica lesions plays a role in their formation. Acta Neuropathol. Commun. 1, 85. doi:10.1186/2051-5960-1-85
206. Popescu, B. F., Lennon, V. A., Parisi, J. E., Howe, C. L., Weigand, S. D., Cabrera-Gomez, J. A., et al. (2011). Neuromyelitis optica unique area postrema lesions: Nausea, vomiting, and pathogenic implications. Neurology 76, 1229-1237. doi:10.1212/WNL.0b013e318214332c
207. Popescu, B. F., and Lucchinetti, C. F. (2012). Pathology of demyelinating diseases. Annu. Rev. Pathol. 7, 185-217. doi:10.1146/annurev-pathol-011811-132443
208. Pott Godoy, M. C., Tarelli, R., Ferrari, C. C., Sarchi, M. I., and Pitossi, F. J. (2008). Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease. Brain 131(Pt 7), 1880-1894. doi:10.1093/brain/awn101
209. Rademakers, R., Baker, M., Nicholson, A. M., Rutherford, N. J., Finch, N., Soto-Ortolaza, A., et al. (2012). Mutations in the colonystimulating factor 1 receptor (CSF1R) gene cause hereditarydiffuse leukoencephalopathywith spheroids. Nat. Genet. 44, 200-205. doi:10.1038/ng.1027
210. Ransohoff, R. M., and Engelhardt, B. (2012). The anatomical and cellular basis of immune surveillance in the central nervous system. Nat. Rev. Immunol. 12, 623-635. doi:10.1038/nri3265
211. Rayaprolu, S., Mullen, B., Baker, M., Lynch, T., Finger, E., Seeley, W. W., et al. (2013). TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementiaand Parkinson's disease. Mol. Neurodegener. 8, 19. doi:10.1186/1750-1326-8-19
212. Reddy, K. C., Andersen, E. C., Kruglyak, L., and Kim, D. H. (2009). Apolymorphism in npr-1 is a behavioral determinant of pathogen susceptibility in C. elegans. Science 323, 382-384. doi:10.1126/science.1166527
213. Rego, A. C., and Oliveira, C. R. (2003). Mitochondrial dysfunction and reactive oxygen species in excitotoxicityand apoptosis: implications for the pathogenesis of neurodegenerative diseases. Neurochem. Res. 28, 1563-1574. doi:10.1023/A1025682611389
214. Reichenberg, A., Gorman, J. M., and Dieterich, D. T. (2005). Interferon-induced depression and cognitive impairment in hepatitis C virus patients: a 72 week prospective study. AIDS 19, S174-S178. doi:10.1097/01.aids.0000192087.64432.ae
215. Reichenberg, A., Yirmiya, R., Schuld, A., Kraus, T., Haack, M., Morag, A., et al. (2001). Cytokine-associated emotional and cognitive disturbances in humans. Arch. Gen. Psychiatry 58, 445-452. doi:10.1001/archpsyc.58.5.445
216. Reinert, K. R., Umphlet, C. D., Quattlebaum, A., and Boger, H. A. (2014). Short-term effects of an endotoxin on substantia nigra dopamine neurons. Brain Res. 1557, 164-170. doi:10.1016/j.brainres.2014.02.005
217. Rezai-Zadeh, K., Gate, D., and Town, T. (2009). CNS infiltration of peripheral immune cells: D-dayfor neurodegenerative disease? J. Neuroimmune Pharmacol. 4, 462-475. doi:10.1007/s11481-009-9166-2
218. Rosas-Ballina, M., Olofsson, P. S., Ochani, M., Valdes-Ferrer, S. I., Levine, Y. A., Rear-don, C., et al. (2011). Acetylcholine-synthesizing T cells relayneural signals in a vagus nerve circuit. Science 334, 98-101. doi:10.1126/science.1209985
219. Rosas-Ballina, M., Valdes-Ferrer, S. I., Dancho, M. E., Ochani, M., Katz, D., Cheng, K. F., et al. (2015). Xanomeline suppresses excessive pro-inflammatory cytokine responses through neural signal-mediated pathways and improves survival in lethal inflammation. Brain Behav. Immun. 44, 19-27. doi:10.1016/j.bbi.2014.07.010
220. Rosen, D. R. (1993). Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 364, 362. doi:10.1038/364362d0
221. Saadoun, S., Waters, P., Bell, B. A., Vincent, A., Verkman, A. S., and Papadopoulos, M. C. (2010). Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. Brain 133(Pt 2), 349-361. doi:10.1093/brain/awp309
222. Sahay, A., and Hen, R. (2007). Adult hippocampal neurogenesis in depression. Nat. Neurosci. 10, 1110-1115. doi:10.1038/nn1969
223. Saji, E., Arakawa, M., Yanagawa, K., Toyoshima, Y., Yokoseki, A., Okamoto, K., et al. (2013). Cognitive impairment and cortical degeneration in neuromyelitis optica. Ann. Neurol. 73, 65-76. doi:10.1002/ana.23721
224. Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., et al. (2003). Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301, 805-809. doi:10.1126/science.1083328
225. Sarkar, A., Mitra, S., Mehta, S., Raices, R., and Wewers, M. D. (2009). Monocyte derived microvesicles deliver a cell death message via encapsulated caspase-1. PLoS ONE 4:e7140. doi:10.1371/journal.pone.0007140
226. Satapathy, S. K., Ochani, M., Dancho, M., Hudson, L. K., Rosas-Ballina, M., Valdes-Ferrer, S. I., et al. (2011). Galantamine alleviates inflammation and other obesity-associated complications in high-fat diet-fed mice. Mol. Med. 17, 599-606. doi:10.2119/molmed.2011.00083
227. Schmitt, C., Strazielle, N., and Ghersi-Egea, J. F. (2012). Brain leukocyte infiltration initiated by peripheral inflammation or experimental autoimmune encephalomyelitis occurs through pathways connected to the CSF-filled compartments of the forebrain and midbrain. J. Neuroinflammation 9, 187. doi:10.1186/1742-2094-9-187
228. Schneider, R., Mohebiany, A. N., Ifergan, I., Beauseigle, D., Duquette, P., Prat, A., et al. (2011). B cell-derived IL-15 enhances CD8 T cell cytotoxicityand is increased in multiple sclerosis patients. J. Immunol. 187, 4119-4128. doi:10.4049/jimmunol.1100885
229. Schwartz, M., and Baruch, K. (2014). The resolution of neuroinflammation in neu-rodegeneration: leukocyte recruitment viathe choroid plexus. EMBO J. 33, 7-22. doi:10.1002/embj.201386609
230. Seki, M., Suzuki, S., Iizuka, T., Shimizu, T., Nihei, Y., Suzuki, N., et al. (2008). Neurological response to early removal of ovarian teratoma in anti-NMDAR encephalitis. J. Neurol. Neurosurg. Psychiatr. 79, 324-326. doi:10.1136/jnnp.2007.136473
231. Semmler, A., Widmann, C. N., Okulla, T., Urbach, H., Kaiser, M., Widman, G., et al. (2013). Persistent cognitive impairment, hippocampal atrophy and EEG changes in sepsis survivors. J. Neurol. Neurosurg. Psychiatr. 84, 62-69. doi:10.1136/jnnp-2012-302883
232. Serafini, B., Rosicarelli, B., Magliozzi, R., Stigliano, E., and Aloisi, F. (2004). Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondaryprogressive multiple sclerosis. Brain Pathol. 14, 164-174. doi:10.1111/j.1750-3639.2004.tb00049.x
233. Shah, D. K., Doyle, L. W., Anderson, P. J., Bear, M., Daley, A. J., Hunt, R. W., et al. (2008). Adverse neurodevelopment in preterm infants with postnatal sepsis or necrotizing enterocolitis is mediated by white matter abnormalities on magnetic resonance imaging at term. J. Pediatr. 153, 170-5, 175.e1. doi:10.1016/j.jpeds.2008.02.033
234. Sharshar, T., Carlier, R., Bernard, F., Guidoux, C., Brouland, J. P., Nardi, O., et al. (2007). Brain lesions in septic shock: amagnetic resonance imaging study. Intensive Care Med. 33, 798-806. doi:10.1007/s00134-007-0598-y
235. Sharshar, T., Gray, F., Lorin de la Grandmaison, G., Hopkinson, N. S., Ross, E., Dorandeu, A., et al. (2003). Apoptosis of neurons in cardiovascular autonomic centres triggered byinducible nitric oxide synthase after death from septic shock. Lancet 362, 1799-1805. doi:10.1016/S0140-6736(03)14899-4
236. Sheedy, F. J., Grebe, A., Rayner, K. J., Kalantari, P., Ramkhelawon, B., Carpenter, S. B., etal. (2013). CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation. Nat. Immunol. 14, 812-820. doi:10.1038/ni.2639
237. Sierra, A., Encinas, J. M., Deudero, J. J., Chancey, J. H., Enikolopov, G., Overstreet-Wadiche, L. S., et al. (2010). Microglia shape adult hippocampal neuroge-nesis through apoptosis-coupled phagocytosis. Cell Stem Cell 7, 483-495. doi:10.1016/j.stem.2010.08.014
238. Silverman, H. A., Dancho, M., Regnier-Golanov, A., Nasim, M., Ochani, M., Olofsson, P. S., etal. (2014). Brain region-specific alterations in the gene expression of cytokines, immune cell markers and cholinergic system components during peripheral endotoxin-induced inflammation. Mol. Med. 20, doi:10.2119/molmed.2014.00147
239. Singer, M. (2014). The role of mitochondrial dysfunction in sepsis-induced multi-organ failure. Virulence 5, 66-72. doi:10.4161/viru.26907
240. Singer, M., De Santis, V., Vitale, D., and Jeffcoate, W. (2004). Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation. Lancet 364, 545-548. doi:10.1016/S0140-6736(04)16815-3
241. Sonneville, R., Verdonk, F., Rauturier, C., Klein, I. F., Wolff, M., Annane, D., et al. (2013). Understanding brain dysfunction in sepsis. Ann. Intensive Care 3, 15. doi:10.1186/2110-5820-3-15
242. Sospedra, M., and Martin, R. (2005a). Antigen-specific therapies in multiple sclerosis. Int. Rev. Immunol. 24, 393-413. doi:10.1080/08830180500371256
243. Sospedra, M., and Martin, R. (2005b). Immunologyofmultiple sclerosis. Annu. Rev. Immunol. 23, 683-747. doi:10.1146/annurev.immunol.23.021704.115707
244. Sporns, O., Tononi, G., and Kotter, R. (2005). The human connectome: a structural description of the human brain. PLoS Comput. Biol. 1:e42. doi:10.1371/journal.pcbi.0010042
245. Stanley, E. R., Berg, K. L., Einstein, D. B., Lee, P. S., Pixley, F. J., Wang, Y., et al. (1997). Biologyand action of colony- stimulating factor-1. Mol. Reprod. Dev. 46, 4-10. doi:10.1002/(SICI)1098-2795(199701)46:1<4::AID-MRD2>3.0.CO;2-V
246. Stern, J. N., Yaari, G., Vander Heiden, J. A., Church, G., Donahue, W. F., Hintzen, R. Q., etal. (2014). B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes. Sci. Transl. Med. 6, 107-248. doi:10.1126/scitranslmed.3008879
247. Stetson, D. B., Ko, J. S., Heidmann, T., and Medzhitov, R. (2008). Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 134, 587-598. doi:10.1016/j.cell.2008.06.032
248. Stevens, B., Allen, N. J., Vazquez, L. E., Howell, G. R., Christopherson, K. S., Nouri, N., et al. (2007). The classical complement cascade mediates CNS synapse elimination. Cell 131, 1164-1178. doi:10.1016/j.cell.2007.10.036
249. Storch, M. K., Piddlesden, S., Haltia, M., Iivanainen, M., Morgan, P., and Lass-mann, H. (1998). Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination. Ann. Neurol. 43, 465-471. doi:10.1002/ana.410430409
250. Tamatani, M., Che, Y. H., Matsuzaki, H., Ogawa, S., Okado, H., Miyake, S., et al. (1999). Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFkappaB activation in primary hippocampal neurons. J. Biol. Chem. 274, 8531-8538. doi:10.1074/jbc.274.13.8531
251. Tektonidou, M. G., Varsou, N., Kotoulas, G., Antoniou, A., and Moutsopoulos, H. M. (2006). Cognitive deficits in patients with antiphospholipid syndrome: association with clinical, laboratory, and brain magnetic resonance imaging findings. Arch. Intern. Med. 166, 2278-2284. doi:10.1001/archinte.166.20.2278
252. Terrando, N., Fidalgo, A. R., Vizcaychipi, M., Cibelli, M., Ma, D., Monaco, C., et al. (2010a). The impact of IL-1 modulation on the development of lipopolysaccharide-induced cognitive dysfunction. Crit. Care 14, 1-9. doi:10.1186/cc9019
253. Terrando, N., Monaco, C., Ma, D., Foxwell, B. M., Feldmann, M., and Maze, M. (2010b). Tumor necrosis factor-alpha triggers a cytokine cascade yielding postoperative cognitive decline. Proc. Natl. Acad. Sci. U.S.A. 107, 20518-20522. doi:10.1073/pnas.1014557107
254. Tian, L., Ma, L., Kaarela, T., and Li, Z. (2012). Neuroimmune crosstalk in the central nervous system and its significance for neurological diseases. J. Neuroinflammation 9, 155. doi:10.1186/1742-2094-9-155
255. Tikka, T., Fiebich, B. L., Goldsteins, G., Keinanen, R., and Koistinaho, J. (2001). Minocycline, a tetracycline derivative, is neuroprotective against excitotoxi-city by inhibiting activation and proliferation of microglia. J. Neurosci. 21, 2580-2588.
256. Ting, J. P., and Trowsdale, J. (2002). Genetic control of MHC class II expression. Cell 109(Suppl.), S21-S33. doi:10.1016/S0092-8674(02)00696-7
257. Titulaer, M. J., Hoftberger, R., Iizuka, T., Leypoldt, F., McCracken, L., Cellucci, T., et al. (2014). Overlapping demyelinating syndromes and anti-N-methyl-D-aspartate receptor encephalitis. Ann. Neurol. 75, 411-428. doi:10.1002/ana.24117
258. Tokunaga, M., Saito, K., Kawabata, D., Imura, Y., Fujii, T., Nakayamada, S., et al. (2007). Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythe-matosus involving the central nervous system. Ann. Rheum. Dis. 66, 470-475. doi:10.1136/ard.2006.057885
259. Trapp, B. D., and Nave, K. A. (2008). Multiple sclerosis: an immune or neurodegen-erative disorder? Annu. Rev. Neurosci. 31, 247-269. doi:10.1146/annurev.neuro.30.051606.094313
260. Valdes-Ferrer, S. I. (2014). The challenges of long-term sepsis survivors: When surviving is just the beginning. Rev. Invest. Clin. 66, 439-449.
261. Valdes-Ferrer, S. I., Rosas-Ballina, M., Olofsson, P. S., Lu, B., Dancho, M. E., Li, J., et al. (2013a). HMGB1 mediates persistent splenocyte priming in sepsis survivors: evidence from a murine model. Shock 40, 492-495. doi:10.1097/SHK.0000000000000050
262. Valdes-Ferrer, S. I., Rosas-Ballina, M., Olofsson, P. S., Lu, B., Dancho, M. E., Ochani, M., et al. (2013b). HMGB1 mediates splenomegaly and expansion of splenic CD11b+ Ly-6C inflammatory monocytes in murine sepsis survivors. J. Intern. Med. 274, 381-390. doi:10.1111/joim.12104
263. Valdes-Ferrer, S. I., Vega, F., Cantu-Brito, C., Ceballos-Ceballos, J., Estanol, B., Garcla-Ramos, G., et al. (2008). Cerebral changes in SLE with or without antiphos-pholipid syndrome. A case-control MRI study. J. Neuroimaging 18, 62-65. doi:10.1111/j.1552-6569.2007.00183.x
264. Verderio, C., Muzio, L., Turola, E., Bergami, A., Novellino, L., Ruffini, F., et al. (2012). Myeloid microvesicles are a marker and therapeutic target for neuroinflammation. Ann. Neurol. 72, 610-624. doi:10.1002/ana.23627
265. Wang, J. H., Pappas, D., De Jager PL, Pelletier, D., de Bakker, P. I., Kappos, L., et al. (2011). Modeling the cumulative genetic risk for multiple sclerosis from genome-wide association data. Genome Med. 3, 3. doi:10.1186/gm217
266. Wang, X. J., Kong, K. M., Qi, W. L., Ye, W. L., and Song, P. S. (2005). Interleukin-1 beta induction of neuron apoptosis depends on p38 mitogen-activated protein kinase activity after spinal cord injury. Acta Pharmacol. Sin. 26, 934-942. doi:10.1111/j.1745-7254.2005.00055.x
267. Waters, P. J., McKeon, A., Leite, M. I., Rajasekharan, S., Lennon, V. A., Villalo-bos, A., et al. (2012). Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. Neurology 78, 665-671. doi:10.1212/WNL.0b013e318248dec1
268. Watts, D. J., and Strogatz, S. H. (1998). Collective dynamics of'small-world' networks. Nature 393, 440-442. doi:10.1038/30918
269. Weiss, N., Miller, F., Cazaubon, S., and Couraud, P. O. (2009). The blood-brain barrier in brain homeostasis and neurological diseases. Biochim. Biophys. Acta 1788, 842-857. doi:10.1016/j.bbamem.2008.10.022
270. Whitney, N. P., Eidem, T. M., Peng, H., Huang, Y., and Zheng, J. C. (2009). Inflammation mediates varying effects in neurogenesis: relevance to the pathogenesis of brain injuryand neurodegenerative disorders. J. Neurochem. 108, 1343-1359. doi:10.1111/j.1471-4159.2009.05886.x
271. Wingerchuk, D. M., Hogancamp, W. F., O'Brien, P. C., and Weinshenker, B. G. (1999). The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 53, 1107-1114. doi:10.1212/WNL.53.5.1107
272. Wolf, S. A., Steiner, B., Akpinarli, A., Kammertoens, T., Nassenstein, C., Braun, A., et al. (2009). CD4-positive T lymphocytes provide a neuroimmunological link in the control of adult hippocampal neurogenesis. J. Immunol. 182, 3979-3984. doi:10.4049/jimmunol.0801218
273. Wong, M. L., Rettori, V., al-Shekhlee, A., Bongiorno, P. B., Canteros, G., McCann, S. M., et al. (1996). Inducible nitric oxide synthase gene expression in the brain during systemic inflammation. Nat. Med. 2, 581-584. doi:10.1038/nm1196-1170a
274. Wyss-Coray, T., Yan, F., Lin, A. H., Lambris, J. D., Alexander, J. J., Quigg, R. J., et al. (2002). Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice. Proc. Natl. Acad. Sci. U.S.A. 99, 10837-10842. doi:10.1073/pnas.162350199
275. Yee, C., Yang, W., and Hekimi, S. (2014). The intrinsic apoptosis pathway mediates the pro-longevity response to mitochondrial ROS in C. elegans. Cell 157, 897-909. doi:10.1016/j.cell.2014.02.055
276. Yokoo, H., Chiba, S., Tomita, K., Takashina, M., Sagara, H., Yagisita, S., et al. (2012). Neurodegenerative evidence in mice brains with cecal ligation and puncture-induced sepsis: preventive effect of the free radical scavenger edaravone. PLoS ONE 7:e51539. doi:10.1371/journal.pone.0051539
277. Yu, L., Chibnik, L. B., Srivastava, G. P., Pochet, N., Yang, J., Xu, J., et al. (2015). Association of brain DNA methylation in SORL1, ABCA7, HLA-DRB5, SLC24A4, and BIN1 with pathological diagnosis of Alzheimer disease. JAMANeurol. 72, 15-24. doi:10.1001/jamaneurol.2014.3049
278. Zhang, B., Gaiteri, C., Bodea, L. G., Wang, Z., McElwee, J., Podtelezhnikov, A. A., etal. (2013). Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease. Cell 153, 707-720. doi:10.1016/j.cell.2013.03.030
279. Zitvogel, L., Kepp, O., and Kroemer, G. (2010). Decoding cell death signals in inflammation and immunity. Cell 140, 798-804. doi:10.1016/j.cell.2010.02.015